10x Genomics, Inc. financial data

Symbol
TXG on Nasdaq
Industry
Laboratory Analytical Instruments
Location
6230 Stoneridge Mall Road, Pleasanton, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 510 % -2.52%
Quick Ratio 72.2 % +3.56%
Debt-to-equity 28.6 % +6.6%
Return On Equity -32.7 % -50.9%
Return On Assets -25.5 % -48.9%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 119M shares +3.39%
Entity Public Float 5.7B USD +26.7%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 120M shares +2.88%
Weighted Average Number of Shares Outstanding, Diluted 120M shares +2.88%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 632M USD +11.1%
Cost of Revenue 223M USD +48.6%
Operating Income (Loss) -253M USD -41.9%
Nonoperating Income (Expense) 20M USD +72.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -233M USD -39.8%
Income Tax Expense (Benefit) 6.56M USD +21%
Net Income (Loss) Attributable to Parent -240M USD -39.2%
Earnings Per Share, Basic -2.03 USD/shares -37.2%
Earnings Per Share, Diluted -2.03 USD/shares -37.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 359M USD +63.5%
Accounts Receivable, after Allowance for Credit Loss, Current 91.2M USD +3.98%
Inventory, Net 88.3M USD +5.48%
Assets, Current 579M USD -0.65%
Property, Plant and Equipment, Net 263M USD -7.59%
Operating Lease, Right-of-Use Asset 60.9M USD -14.3%
Intangible Assets, Net (Excluding Goodwill) 16.7M USD -25.3%
Goodwill 4.51M USD 0%
Other Assets, Noncurrent 5.19M USD -74.6%
Assets 930M USD -6.06%
Accounts Payable, Current 21.2M USD -8.11%
Employee-related Liabilities, Current 20.1M USD -10.3%
Contract with Customer, Liability, Current 16.4M USD +78.3%
Liabilities, Current 111M USD +13.2%
Contract with Customer, Liability, Noncurrent 11.4M USD
Operating Lease, Liability, Noncurrent 78.7M USD -12.9%
Other Liabilities, Noncurrent 4.57M USD -42.3%
Liabilities 206M USD +4.72%
Accumulated Other Comprehensive Income (Loss), Net of Tax -430K USD +55.6%
Retained Earnings (Accumulated Deficit) -1.38B USD -21%
Stockholders' Equity Attributable to Parent 724M USD -8.73%
Liabilities and Equity 930M USD -6.06%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.7M USD -281%
Net Cash Provided by (Used in) Financing Activities 1.64M USD
Net Cash Provided by (Used in) Investing Activities 10.6M USD -91.1%
Common Stock, Shares Authorized 1.1B shares 0%
Common Stock, Shares, Issued 119M shares +3.39%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.5M USD -103%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 380M USD +14.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 443M USD +21.6%
Deferred Tax Assets, Gross 460M USD +20.3%
Operating Lease, Liability 89.5M USD -10.2%
Payments to Acquire Property, Plant, and Equipment 2.91M USD -36.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -239M USD -41.3%
Lessee, Operating Lease, Liability, to be Paid 111M USD -12.3%
Property, Plant and Equipment, Gross 379M USD +2.24%
Operating Lease, Liability, Current 10.8M USD +16.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 15.4M USD +0.66%
Lessee, Operating Lease, Liability, to be Paid, Year One 14.8M USD -9.44%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 21.1M USD -20.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 15.6M USD -2.78%
Deferred Tax Assets, Operating Loss Carryforwards 167M USD -4.81%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 45.7M USD +44%
Lessee, Operating Lease, Liability, to be Paid, Year Four 15.7M USD +1.94%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 9.19M USD +41.8%
Deferred Tax Assets, Net of Valuation Allowance 17.4M USD -5.8%
Share-based Payment Arrangement, Expense 154M USD -5.24%
Interest Expense 15K USD -95.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%